Arsenic(V) removal with polymer inclusion membranes from sulfuric acid media using DBBP as carrier.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 14968878)

Published in Environ Sci Technol on February 01, 2004

Authors

Ma de Lourdes Ballinas1, Eduardo Rodríguez de San Miguel, Ma Teresa de Jesús Rodríguez, Orlando Silva, María Muñoz, Josefina de Gyves

Author Affiliations

1: Departamento de Química Analítica, Facultad de Química, UNAM, Ciudad Universitaria, 04510 México, D.F. México.

Articles citing this

Arsenic removal by liquid membranes. Membranes (Basel) (2015) 0.77

Articles by these authors

Progress against solid tumors in danger: the metastatic breast cancer example. J Clin Oncol (2012) 2.05

Intermatrix synthesis: easy technique permitting preparation of polymer-stabilized nanoparticles with desired composition and structure. Nanoscale Res Lett (2011) 1.68

Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer. J Clin Oncol (2006) 1.60

Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer. Breast Cancer Res Treat (2010) 1.14

Paclitaxel albumin-bound particles (abraxane) in combination with bevacizumab with or without gemcitabine: early experience at the University of Miami/Braman Family Breast Cancer Institute. Biomed Pharmacother (2007) 1.03

Primary ectopic breast cancer presenting as a vulvar mass. Clin Breast Cancer (2006) 1.01

Small-cell cancer of the breast: what is the optimal treatment? A report and review of outcomes. Clin Breast Cancer (2012) 0.93

Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy: a multicenter, randomized, phase II trial. J Thorac Oncol (2007) 0.93

Evaluation of different mediator-modified screen-printed electrodes used in a flow system as amperometric sensors for NADH. Talanta (2006) 0.93

Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC). Lung Cancer (2006) 0.90

Micellar solutions of sulfobetaine surfactants in water-ethylene glycol mixtures: surface tension, fluorescence, spectroscopic, conductometric, and kinetic studies. Langmuir (2005) 0.88

Intermatrix synthesis of polymer stabilized inorganic nanocatalyst with maximum accessibility for reactants. Dalton Trans (2009) 0.88

Weekly docetaxel/carboplatin as primary systemic therapy for HER2-negative locally advanced breast cancer. Clin Breast Cancer (2005) 0.86

Prevalence of hepatitis C infection in patients with non-Hodgkin's lymphoma in South Florida and review of the literature. Leuk Lymphoma (2004) 0.85

Barriers to HCV treatment in the era of triple therapy: a prospective multi-centred study in clinical practice. Liver Int (2014) 0.83

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere. Cancer Chemother Pharmacol (2014) 0.82

Images in cardiovascular medicine. Giant endocardial blood cyst in the right atrium: echocardiographic and magnetic resonance imaging features. Circulation (2008) 0.81

Nephrotoxicosis in Iberian piglets subsequent to exposure to melamine and derivatives in Spain between 2003 and 2006. J Vet Diagn Invest (2009) 0.81

New insight into the SSC8 genetic determination of fatty acid composition in pigs. Genet Sel Evol (2014) 0.80

Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome. Am J Ther (2012) 0.79

Differences in the peripheral immune response between lambs and adult ewes experimentally infected with Mycobacterium avium subspecies paratuberculosis. Vet Immunol Immunopathol (2011) 0.78

X-Ray Photoelectron Spectroscopy Analysis of Di-(2-ethylhexyl) Phosphoric Acid Activated Membranes. J Colloid Interface Sci (2000) 0.78

Kinetic study in water-ethylene glycol cationic, zwitterionic, nonionic, and anionic micellar solutions. Langmuir (2004) 0.77

Models of α-synuclein aggregation in Parkinson's disease. Acta Neuropathol Commun (2014) 0.77

A myxoid chondrosarcoma associated with an anti-Hu-positive paraneoplastic encephalomyelitis. J Neurooncol (2010) 0.77

Water-N,N-dimethylformamide alkyltrimethylammonium bromide micellar solutions: thermodynamic, structural, and kinetic studies. Langmuir (2005) 0.76

Effects of ethylene glycol addition on the aggregation and micellar growth of gemini surfactants. Langmuir (2006) 0.76

[Maternal morbidity and perinatal mortality in HELLP syndrome. Multicentric studies in intensive care units in Buenos Aires area]. Medicina (B Aires) (2005) 0.76

[Cost of screening for hepatocarcinoma in patients with cirrhosis: a prospective study]. Gastroenterol Hepatol (2011) 0.75

catena-Poly[bromo(omega-thiocaprolactam-kappaS)gold(I)](Au-Au). Acta Crystallogr C (2004) 0.75

Non-compaction cardiomyopathy and polycystic kidney disease. Nephrology (Carlton) (2010) 0.75

Self-oriented Ag-based polycrystalline cubic nanostructures through polymer stabilization. Nanotechnology (2016) 0.75

Role of the counterion in the effects of added ethylene glycol to aqueous alkyltrimethylammonium micellar solutions. J Colloid Interface Sci (2006) 0.75

Chilean primary health workers' knowledge about folic acid supplementation for the prevention of neural tube defects. Am J Med Genet A (2006) 0.75